The Australian study is expected to be the world's largest on the health economic impact of medical cannabis.
Diagnosed with MS aged 21, Lezley Gibson supplied medical cannabis to patients across the country.
The world’s first randomised controlled trial for cannabis as a migraine treatment is underway in the US.
CBD experts at Always Pure Organics give us an exclusive look behind the scenes
Despite a host country in an official state of emergency, the Olympics will reportedly go ahead this summer. This is against the wishes of 80 per...
Affecting more than 10 million people in the UK, arthritis is a common condition that causes pain and inflammation in our joints. Contrary to popular belief,...
Medical cannabis and pain – new findings see that almost 90 per cent of patients using medical cannabis to treat pain find it to be more...
An expert on CBD has called the rollout of the novel food regulations on the CBD industry ‘horrendously slow’. Sarah Ellson, a lawyer at Fieldfisher, said...
Health anxiety is a recognised condition, characterised by obsessive thoughts about becoming or being ill.
Medical cannabis company MGC Pharma is pressing ahead with clinical trials despite ‘hurdles’ created by the pandemic. The London Stock Exchange-listed firm has reported updates on...
Sponsored feature Rebel Wine is joining the chat around CBD and HEMP! What is Rebel wine? Rebel Wine is the first CBD wine in can in...